A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
NCT06147856
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
The Sponsor no longer intends to recruit to this study.
Conditions
Phenylketonuria
Interventions
DRUG:
mRNA-3210
Sponsor
ModernaTX, Inc.